Categories: Business News

How are you capping drug prices in absence of guidelines: High Court to NPPA

New Delhi, October 01, 2014 – The Delhi High Court today asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising its power to cap prices of non-scheduled drugs in view of the recent withdrawal of the guidelines issued for the purpose.

“It’s not that you do not have the power for carrying out the exercise, it’s the manner in which you exercise it that is being questioned,” the bench said after the counsel for the NPPA contended that withdrawal of the guidelines has not taken away the authority’s power to fix prices.
“File an affidavit indicating framework within which prices for non-scheduled drugs are now sought to be sustained in the absence of the guidelines,” it said.
The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers had on September 19 ordered the NPPA to withdraw a guideline under the Drug (Prices Control) Order (DPCO) of 2013 that gave the pricing authority powers to cap prices of non-scheduled drugs.

The NPPA had on the basis of the May 29 guideline issued a notification on July 10 capping prices of 108 anti-diabetic and cardiovascular drugs.

Senior advocate Kapil Sibal, appearing for the Organisation of Pharma Producers of India (OPPI), said since the guidelines for the price fixation of drugs has been withdrawn, it would also affect the operation of the July 10 notification.
The OPPI has moved the court challenging the notification and seeking an order preventing the government from taking any further steps in pursuance of the same.

The NPPA submitted before the court that only some internal guidelines were withdrawn and the same would not in any way affect the July 10 notification.

The court, however, directed the authority to file an affidavit making its stand clear on the issue. PTI
The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau
10 years ago

Recent Posts

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

2 days ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

2 days ago

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

3 days ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

3 days ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

4 days ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

4 days ago